Agoracom Blog

Loop Insights $MTRX.ca Announces Reseller Partnership And First Sale With Vend, A Global POS Company Used In 25,000 Stores Across 140 Countries $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:09 AM on Monday, August 10th, 2020
Loop Insights – Medium
  • Announced the signing of a channel reseller partnership with global cloud-based Point-of-Sale (POS) company, Vend, as well as, the first sale to a Vend client
  • Vend is the first POS built for iOS and is now used in over 25,000 stores across 140 countries. Vend’s fast growth and global reach creates opportunities across the world for Loop and its technology in the retail vertical.
  • First Implementation with Wild Bird Centers of America Inc. Franchise

VANCOUVER, BC, Aug. 10, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, automated marketing, and contact tracing to the brick and mortar space, is pleased to announce the signing of a channel reseller partnership with global cloud-based Point-of-Sale (POS) company, Vend, as well as, the first sale to a Vend client.

VEND UNLOCKS ACTIVE OPPORTUNITIES IN $5T GLOBAL RETAIL INDUSTRY

Vend is the first POS built for iOS and is now used in over 25,000 stores across 140 countries. Vend’s fast growth and global reach creates opportunities across the world for Loop and its technology in the retail vertical.  To this end, the companies have already secured the first implementation at a Vend client, Wild Birds Centers of America Inc. – a North American aviary retail franchise with 30 stores – and subsidiary of Global Harvest Foods Ltd.  Loop plans on widening the scope of opportunity Global Harvest Foods. 

Furthermore, Vend is already in discussions with several other retail chains and both companies expect to announce additional implementations in the near future. 

Loop Insights CEO, Rob Anson stated “This is a significant partnership for Loop given the fact both companies offer cloud-based services that provide a strong foundation for rapid scalability and growth. We are both driven to acquire multi-store clients to drive faster, larger adoption rates. As seen by our first implementation with Wild Bird Centers of America, VendHQ is already demonstrating huge value to Loop as a channel reseller. With active conversations already taking place with many of Vend’s global clients, our goals for global penetration into retail are already taking shape.”  

Jake West, Director of Business Development at Vend stated “We are beyond excited to be partnering with Loop Insights to provide our retailers with robust, enterprise-level tools.  With COVID 19, Vend has seen an increase in the number of mid-market and enterprise retailers that are moving to Vend to take advantage of modern, cloud-based technology. Loop Insights is a perfect complement to Vend’s platform, in that, collectively we are able to deliver enterprise & franchise reporting tools, deep product insights and even trends on consumer behavior to our retailers. Vend has long had a partner focused approach, where we partner with the best-of-breed companies like Loop to deliver our clients with an overall superior experience.  

LOOP’S SOFTWARE INTEGRATION CREATES SCALABLE CHANNEL RESELLER OPPORTUNITIES  

The addition of Loop’s API provides Vend clients the unique ability to connect transactional data across all physical retail locations and e-commerce platforms for single stores, multi-store franchises, and international enterprise retail customers. The companies will first integrate Loop’s powerful insights service at Wild Bird Centers of America—a franchise with 30 retail stores in Canada and the United States; Loop plans on widening the scope of opportunity to its umbrella company, Global Harvest Foods Ltd. 

Without the need for hardware, Loop Cloud delivers a frictionless implementation process that allows for large-scale adoption and, ultimately, adds high margin revenue-generating power to Loop’s current Software as a Service(SaaS) revenuemodel. As a channel reseller for Loop’s technology, the companies anticipate revenue from onboarding fees and SaaS fees. Loop’s software API integration also supports seamless access to its other AI-driven services: automated personalized engagement and programmatic advertising. The addition of these services would increase the clients’ monthly SaaS fees, and add additional revenue for Loop through distribution/redemption of third-party promotions. 

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion 

About Vend: Vend is a cloud-based point-of-sale and retail management software that lets retailers run their business in-store, online, and on-the-go. Vend includes inventory management, Ecommerce integrations, customer loyalty, and reporting analytics tools. The first POS built for iOS, Vend is trusted by retailers in over 140 countries and is used in more than 25,000 stores worldwide. Vend integrates with leading tools like Bigcommerce, Quickbooks and Marsello and provides seamless integrated payment options by partnering with major banks and processors around the world. Founded in 2010, Vend has offices in Auckland, London, Toronto and Melbourne, and has raised more than $50 million from top-tier investors.  For more information, please visit: https://www.vendhq.com/ 

About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

Forward-Looking Statements/Information:  

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  

LOOP Website: www.loopinsights.ai   

Facebook: @LoopInsights 

Twitter: @LoopInsights 

LinkedIn: @LoopInsights 

SOURCE LOOP Insights Inc. 

Avicanna Inc. $AVCN.ca to Host Second Quarter 2020 Investor Conference Call $CRDL.ca $PCLO.ca $WEED.ca $ACB.ca

Posted by AGORACOM-JC at 6:46 PM on Friday, August 7th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

TORONTO, Aug. 7, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that it has scheduled a conference call on Monday, August 17, 2020 at 9:00AM Eastern Time to discuss the results for its fiscal second quarter ended June 30, 2020. Aras Azadian, Chief Executive Officer and Davender Sohi, Chief Financial Officer, will host the call and a question and answer period. The Company will report its financial results for the second quarter after the close of markets on Friday, August 14, 2020.

            Conference Call Details

DATE:                                           August 17, 2020                                   
TIME:  9:00 AM Eastern Time
  
CONFIRMATION #:                             64751998
  
TORONTO:                                           416-764-8659
NORTH AMERICAN TOLL FREE:         1-888-664-6392
GERMANY TOLL FREE:   08007240293
COLOMBIA TOLL FREE:      018005184036
  
REPLAY TORONTO:                             416-764-8677  
REPLAY NORTH AMERICA:    1-888-390-0541 
REPLAY ENTRY CODE:   751998#
REPLAY EXPIRATION DATE:               August 24, 2020

About Avicanna Inc.

Avicanna is an Ontario, Canada based corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.

Avicanna’s two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna’s cultivation activities. These two companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC).

Avicanna’s research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna’s scientific team develops products, and Avicanna has also engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto for the purpose of optimizing and improving upon its products.

Avicanna’s research and development and cultivation activities are focused on the development of its key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and Extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates), with a goal of eventually having these products manufactured and distributed through various markets.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated April 15, 2020 (the “AIF“) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE Avicanna Inc.

Terry Booth Schedules Investor Conference Call to Discuss Binovi’s $VISN.ca New Direction $EYPT $KALA

Posted by AGORACOM-JC at 4:16 PM on Friday, August 7th, 2020
http://www.smallcapepicenter.com/binovi%20square.png
  • Executive Chairman Terry Booth wishes to set up a special investor conference call to discuss the Company’s new direction
  • The call will be hosted on Tuesday, August 11th, 2020 with Binovi Technologies Executive Chairman, Terry Booth and Adam Cegielski, CEO.

Toronto, New York – August 7, 2020 – Binovi Technologies Corp., (Binovi) (TSXV:VISN) | (OTC:BNVIF) announces that in light of the latest developments, Executive Chairman Terry Booth wishes to set up a special investor conference call to discuss the Company’s new direction. The call will be hosted on Tuesday, August 11th, 2020 with Binovi Technologies Executive Chairman, Terry Booth and Adam Cegielski, CEO.

The call will be held on Tuesday August 11th, at 4:15pm EST (1:15pm PST).

Conference details:

Canada/USA TF: 1-800-319-4610
International Toll: +1-604-638-5340
Germany TF: 0800-180-1954

Callers should dial in 5 – 10 min prior to the scheduled start time and simply ask to join the call.

Conference replay

Canada/USA TF: 1-800-319-6413
International Toll: +1-604-638-9010
Replay Access Code: 5088

For additional information on the Company, please visit https://www.binovi.com/investor-reports/

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 1,500 locations across 20 countries.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.binovi.com/investor-reports/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Innocan’s $INNO.ca SHIR (TM) Beauty & Science #CBD Derma Cosmetics Products Passed Safety Assessments and Have Been Approved for Marketing in the European Union $GWPH $CRDL.ca $PCLO.ca

Posted by AGORACOM-JC at 4:45 PM on Thursday, August 6th, 2020
Innocan-Blog
  • Announced that its SHIR™ CBD Derma Cosmetic product line, has successfully passed safety assessment in accordance with European Union (EU) cosmetic regulation No 1223/2009 and received a EU Cosmetic Product Safety Report for marketing in the European Union
  • SHIR™ skincare products combine the benefits of CBD with the most effective ingredients in an innovative formula to deliver visible results
  • The SHIR™ Beauty & science products that are approved for marketing in the Europe are: SHIR CBD+ ANTI-AGING Beauty Sleeping Mask ,SHIR CBD MUST Eye Serum, SHIR CBD MUST Recovery Lotion, SHIR CBD MUST Glow Oil, SHIR CBD MUST Face Cream, SHIR CBD+ ANTI-AGING Facial Serum

Herzliya, Israel and Calgary, Alberta–(August 6, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that its SHIR™ CBD Derma Cosmetic product line, has successfully passed safety assessment in accordance with European Union (EU) cosmetic regulation No 1223/2009 and received a EU Cosmetic Product Safety Report for marketing in the European Union.

SHIR™ skincare products combine the benefits of CBD with the most effective ingredients in an innovative formula to deliver visible results. The SHIR™ Beauty & science products that are approved for marketing in the Europe are: SHIR CBD+ ANTI-AGING Beauty Sleeping Mask ,SHIR CBD MUST Eye Serum, SHIR CBD MUST Recovery Lotion, SHIR CBD MUST Glow Oil, SHIR CBD MUST Face Cream, SHIR CBD+ ANTI-AGING Facial Serum.

Innocan’s SHIR™ Beauty & Science CBD Derma Cosmetics

https://orders.newsfilecorp.com/files/6922/61225_6b37fecc040dc9bd_002full.jpg



To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6922/61225_6b37fecc040dc9bd_002full.jpg

“As a Pharma Company, Innocan is committed to creating premium products that meet the highest quality standards to provide consumer confidence,” Iris Bincovich, co-founder and CEO of Innocan states. “Compliance with EU regulation is a major milestone for us, following the receipt of technical validation from the FDA for the marketing in the US of our over-the-counter Relief & Go Pain Relief spray, a few weeks ago. The next step is to initiate our various distribution platforms to deliver our SHIR™ CBD Derma Cosmetic line across the European Union and other markets where legally permitted to do so.”

About Innocan

The Company, through its wholly owned subsidiary, Innocan Pharma Ltd., is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 Corona Virus using CBD. CBD-Loaded Exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release Liposome to be administrated by Injection. The Company plans, together with Prof. Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University to test the Liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, the effectiveness and safety of the Company’s products, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

VIDEO – ImagineAR $IP.ca $IPNFF Adds Media Powerhouse Michael Anderson To Spearhead UK & Euro Sales $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 4:30 PM on Thursday, August 6th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

If you were a small cap Augmented Reality company from Vancouver that needed to appoint an old media / new media powerhouse to head up your European sales operations, we really don’t think you could have found someone better credentialed than Michael Anderson – and that’s exactly what ImagineAR (IP:CSE) (IPNFF:OTCQB) did.  

Anderson is a highly regarded leader in the world of digital with his roots firmly based in UK media. Part entrepreneur, part corporate animal, he quickly rose through the ranks ending up as Managing Director of News UK. He worked for Rupert Murdoch and Les Hinton during his rise to the top and made the Board room of both News UK and Associated Newspapers (publishers of the Daily Mail).   

Sensing the changing winds of the media business, Anderson was a driving force on the launch team of Metro, which overtook The Sun in 2018 as the largest circulation of any newspaper in the UK.  At Metro, he was instrumental in the paper being cited as a new business case with commercial results not seen previously in the newspaper industry, growing revenue from £100k a week to £1m per week in just 12 months.  Additionally, Mike was the founder of the Chelsea APPS Factory which included UK clients KPMG, Ladbrokes, Standard Life, TfL, Vanquis and Waitrose.    

….. And now he is sensing another change in the winds to put his considerable talents and team behind the Augmented Reality solutions of ImagineAR.  

If you don’t know what Augmented Reality (AR) is, this quote from Apple CEO Tim Cook is all the motivation you need to get up to speed:  

“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phone”  

 Anderson wholeheartedly agrees, stating “ImagineAR is the most advanced AR platform in the market today and I am excited to launch the company’s sales and marketing initiatives in the UK and Europe.”  

That quote is just the tip of the iceberg.  Watch what Anderson has to say about the “unlimited possibilities of Augmented Reality” and some pretty good hints about whose doors he will be knocking on first …. which is pretty impressive given the fact August is vacation season in Europe 🙂   

If our interview with CEO Alen Paul Silverrstieen and Michael Anderson is any indication, it sounds like the Company’s growth into the UK and Europe is all but assured in 2020 and well beyond.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Else Nutrition $BABY.ca Provides Corporate Update $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 1:02 PM on Thursday, August 6th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020
  • A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner
  • The Company’s Amazon.com store will launch in the coming weeks

VANCOUVER, BC /August 6, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide the following corporate update.

“Our team has been working relentlessly, during an unprecedently difficult time, to bring our product to market. As we get set to launch, we are beyond thrilled to have crossed major hurdles over the past months and weeks – including full scale manufacturing with a U.S. based partner and mobilization of our U.S. supply chain which has culminated in our ability to ship samples of our plant-based formula for toddlers to eager parents across North America,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else.

North America Launch

The Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020. A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner. The Company’s Amazon.com store will launch in the coming weeks.

U.S. Manufacturing

The first full-scale commercial manufacturing run of the toddler nutrition powder product was successfully completed by the Company’s U.S. manufacturing partner and packed at a co-packer plant in Nevada.

The terms of the U.S. manufacturing agreement have been negotiated and a formal agreement will be executed upon the receipt of final yield and cost optimization parameters. The next commercial manufacturing run is booked and secured.

FDA Regulatory Pathway

The Company in conjunction with its FDA consulting partner continues to progress on the regulatory pathway for multiple products including an infant formula and new products currently in development for the adult nutrition market.

Health and Happiness International Holdings Limited

The Company’s negotiations with its strategic partner, H&H Global, for distribution rights of the toddler and infant formula in France are advancing well. The parties are studying the target market needs, channels, and regulations, in addition to preparing a launch plan and negotiating the distribution terms. Additionally, discussions regarding distribution in additional markets have also commenced.

Cash and Runway

The company is well capitalized, with approximately CAD$7.0 million in cash, and no short or long-term debt, to fully support its manufacturing and go-to-market plans for the next 12 months.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

VIDEO – Kontrol Energy $KNR.ca Technology Could Detect #COVID19 In Big Buildings Through Real-Time Air Sampling & Alerts $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 10:14 AM on Thursday, August 6th, 2020
kontrol-logo

If Google NEST is the leader in smart home technology, then Kontrol Energy (KNR:CSE) is the small cap equivalent for smart building technology.  More than just lip service, their established Blue Chip customer base includes:

  • Beyond Meat
  • Oxford Properties
  • Brookfield Asset Management
  • Telus
  • Suncor Energy
  • ….. Many More

Moreover, they’ve signed a major deal wth Toyota (Tsusho Canada), targeting 200 plants requiring up to $1 million each in automation retrofits.

CONCLUSION?  When Kontrol Energy says they are entering a 4-week testing phase – with an independent lab – to determine if their technology can detect COVID-19 in the air of big buildings, you need to take the news seriously.  You know who else took it seriously?  The National Research Council, who granted Kontrol $50,000 to conduct the test.  The amount may seem small but that’s because KNR has already done most of the leg work already and is now in the final 4-week testing phase.  

If successful, the implications could be enormous for their Tier-1 client base, as well as, all commercial buildings, government buildings, schools and other big essential locations that need to find a way to start bringing people back.  In short, Kontrol Energy’s BioCloud Analyzer could have a major impact on the North American economy.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Labrador Gold $LAB.ca Announces Start of Exploration at Kingsway $RIO.ca $WHM.ca $SIC.ca $NXS.ca $NVO.ca $CFE.ca

Posted by AGORACOM at 9:24 AM on Thursday, August 6th, 2020

TORONTO, Aug. 06, 2020 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX-V: LAB | OTCQB: NKOSF) (“LabGold” or the “Company”) is pleased to announce that its field crew has arrived in Gander and started the 2020 exploration program on the Kingsway Property.

LabGold’s work program will initially focus on following up known gold anomalies identified from previous work on the three licenses. Soil sampling has begun on a high priority target that covers a 3km long anomaly of gold in heavy mineral concentrates with values from <5ppb to 89ppm (89g/t Au) that runs along the interpreted trace of the Appleton fault zone. Geological mapping and prospecting of anomalous areas and known showings is also underway.

Up to 10,000 soil samples and 250 km of ground magnetics/VLF-EM are planned for the property and are expected to take about six weeks to complete. We intend to hit the priority areas with known gold anomalies first so that the results of these surveys, together with the results of the geological mapping and prospecting can be used to plan a first phase fall drilling program.

Concurrently with the field work, we are working on a structural compilation of the district. This compilation will allow us to more efficiently target areas for detailed mapping and prospecting based on a better understanding of the role of primary and secondary structures on the localization of gold mineralization.

“It feels good to get boots on the ground at Kingsway which we believe to be the most strategically located property in the Gander gold district relative to New Found Gold’s recent discovery,” said Roger Moss, President and CEO. “Our focus on soil geochemistry and mag/VLF to define structures and potential alteration zones is consistent with what has worked well in the past and we expect to generate numerous targets along the major structures for drill testing.”

“It’s good to see the Kingsway Project moving along. Our limited 2019 deeper soil program over anomalous gold in till and vegetation samples proved successful in outlining new gold targets that will be followed up during this season’s work,” said Shawn Ryan, Technical Advisor to LabGold. “Based on last year’s success, the proposed larger 10,000 sample soil program covering existing gold in till and vegetation samples should produce some nice new gold anomalies leading to new drill targets.”

Roger Moss, PhD., P.Geo., is the qualified person responsible for all technical information in this release.

The Company gratefully acknowledges the Newfoundland and Labrador Ministry of Natural Resources’ Junior Exploration Assistance (JEA) Program for its financial support for exploration of the Kingsway property.

About Labrador Gold:

Labrador Gold is a Canadian based mineral exploration company focused on the acquisition and exploration of prospective gold projects in Eastern Canada.

In early March 2020, Labrador Gold acquired the option to earn a 100% interest in the Kingsway project in the Gander area of Newfoundland. The property is along strike to the northeast of New Found Gold’s discovery of 92.86 g/t Au over 19.0 metres on their Queensway property. (Note that mineralization hosted on adjacent or nearby properties is not necessarily indicative of mineralization hosted on the Company’s property). In early July 2020, the Company signed an option agreement to acquire a third license to add to the property package which now covers approximately 77 km2. The three licenses comprising the Kingsway project cover approximately 16km of the Appleton fault zone which is associated with gold occurrences in the region, including the New Found Gold discovery. Historical work over the area covered by the Kingsway licenses shows evidence of gold in till, vegetation, soil, stream sediments, lake sediments and float. Infrastructure in the area is excellent located just 18km from the town of Gander with road access to the project, nearby electricity and abundant local water.

The Hopedale property covers much of the Hunt River and Florence Lake greenstone belts that stretch over 80 km. The belts are typical of greenstone belts around the world but have been underexplored by comparison. Initial work by Labrador Gold during 2017 show gold anomalies in soils and lake sediments over a 3 kilometre section of the northern portion of the Florence Lake greenstone belt in the vicinity of the known Thurber Dog gold showing where grab samples assayed up to 7.8g/t gold. In addition, anomalous gold in soil and lake sediment samples occur over approximately 40 kilometres along the southern section of the greenstone belt (see news release dated January 25th 2018 for more details). Labrador Gold now controls approximately 57km strike length of the Florence Lake Greenstone Belt.

The Ashuanipi gold project is located just 35 km from the historical iron ore mining community of Schefferville, which is linked by rail to the port of Sept Iles, Quebec in the south. The claim blocks cover large lake sediment gold anomalies that, with the exception of local prospecting, have not seen a systematic modern day exploration program. Results of the 2017 reconnaissance exploration program following up the lake sediment anomalies show gold anomalies in soils and lake sediments over a 15 kilometre long by 2 to 6 kilometre wide north-south trend and over a 14 kilometre long by 2 to 4 kilometre wide east-west trend. The anomalies appear to be broadly associated with magnetic highs and do not show any correlation with specific rock types on a regional scale (see news release dated January 18th 2018). This suggests a possible structural control on the localization of the gold anomalies. Historical work 30 km north on the Quebec side led to gold intersections of up to 2.23 grams per tonne (g/t) Au over 19.55 metres (not true width) (Source: IOS Services Geoscientifiques, 2012, Exploration and geological reconnaissance work in the Goodwood River Area, Sheffor Project, Summer Field Season 2011). Gold in both areas appears to be associated with similar rock types.

The Company has 91,584,175 common shares issued and outstanding and trades on the TSX Venture Exchange under the symbol LAB.

For more information please contact:             

Roger Moss, President and CEO      Tel: 416-704-8291

Or visit our website at: www.labradorgold.com

Twitter:@LabGoldCorp

Agoracom Welcomes Candente Copper with Canariaco Deposit, Included in Goldman Sachs 84 Top Copper Projects Worldwide $DNT.ca $CN.ca $FCX $BHP $TECK.ca

Posted by AGORACOM at 9:18 AM on Thursday, August 6th, 2020

CANDENTE HIGHLIGHTS:

  • Canariaco Included in Goldman Sachs 84 Top Copper Projects Worldwide
    • Cañariaco in Lowest Quartile of Copper Industry Production Costs
    • Definitive Feasibility 50% Complete
    • Higher grade throughput of 0.54% CuEqMill Feed Grade during first 3 years
    • Rising Copper and Gold Prices Impacting 2011 PFS
  • Fortescue Metals Group Ltd. owns 19.92% interest
    • Joint technical committee created to identify optimum strategy for Cañariaco development

Project Highlights:

Cañariaco Norte is a 100% owned feasibility-stage porphyry copper deposit

  • A single, contiguous, open-pit mineable deposit of 7.5B pounds Measured and Indicated,
  • 1.4B pounds Inferred Porphyry Copper Deposit
  • Annual production of 262,000,000lbs of copper, 39,000 oz gold & 911,000 oz silver over initial mine life of 22 yrs(@ 95,000 tpd)

Pre-Feasibility Study

  • NPV of US $922M and IRR of 17.3% (using US$2.25 copper and an 8% discount rate)
  • Payback of preproduction capital in 4.4 years (after-tax)
  • Copper Production of 262,000,000 pounds per year
  • Initial Mine life of 22 years+
  • Throughput rate of 95,000 tonnes per day
  • Operating costs of US$0.988 per pound of copper (including onsite/offsite costs, taxes and byproduct credits)
  • Minimal infrastructure required, excellent locations for all site facilities, close to existing highway (42km away) and power grid (57km away) & abundant water at site
  • Very strong community & regional support

The Cañariaco Norte Copper Project

  • Canariaco in Top 80 Deposits slated for Development according to Goldman Sachs
    • 42 in South America –Cañariaco Included
    • Cañariaco in Lowest Quartile of Copper Industry Production Costs
  • Large scale porphyry copper–gold-silver deposit in Northern Peru
  • 7.5B pounds Measured and Indicated, plus 1.4B pounds Inferred Porphyry Copper Deposit
  • Deposit and Scope of Project Development well defined by Pre-Feasibility Studies in 2011
  • Annual production of 262,000,000lbs of copper, 39,000 oz gold & 911,000 oz silver over initial mine life of 22 yrs(@ 95,000 tpd)
  • Operating costs of US$0.988 per pound of copper (including onsite/offsite costs, taxes and byproduct credits
  • Strong Government support

Resource and Mine Plan

123 Million tonnes @ 0.58% Cu Eq (0.4% Cu cutoff) Measured

752 Million tonnes @ 0.52% Cu Eq (0.3% Cu cutoff) M & Indicated

1.0 Billion tonnes @ 0.46% Cu Eq(0.2% Cu cutoff) M & I

Current Mine Plan 728.2 Million tonnes @ 0.46% CuEqMill Feed Grade

  • Higher grade throughput of 0.54% CuEqMill Feed Grade during first 3 years

Canariaco Price Sensitivities Chart

  • Rising Copper and Silver Prices dramatically Project Economics
  • Based on 2011 Pre-Feasibility Progress Report

Lomiko Investment $LMR.ca Promethieus Ventures N.V. To List On The Dutch Caribbean Stock Exchange With Ticker DCSX:TECH $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM at 8:56 AM on Thursday, August 6th, 2020

 Vancouver, B.C., Aug. 06, 2020 (GLOBE NEWSWIRE) — Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) Lomiko Metals Inc. announces that it’s participation of 20 % in Promethieus Technologies Inc. (“Promethieus Tech”) will be exchanged for 20 % equity in a new to be formed entity Promethieus Ventures N.V. (“Promethieus N.V.”).which intends to list on the Dutch Caribbean Securities Exchange (DCSX) N.V

The (DCSX) is a self-regulatory international exchange focused on the listing and trading of domestic and international securities. It is a securities exchange platform where companies can raise funding through a large network of global investors. The DCSX is focused on servicing start-ups as well as small and medium-sized enterprises.  The DCSX is located in Curacao, a Lesser Antilles island country in the southern Dutch Caribbean region.

Promethieus N.V. will seek to raise up to 10 million USD to advance the projects currently underway. The listing agent for Promethieus N.V. is Amergeris Global Listing and Exchange Services.  The company has requested and received the ticker symbol ‘TECH’ for Promethieus N.V.

Lomiko confirms that on July 31, 2019  it had entered into an agreement to sell it’s 100% interest in Lomiko Technologies Inc. to Promethieus Technologies Inc. (Canada) for $ 1,236,625 in return for a 20 % equity participation in Promethieus Tech. Lomiko subsequently provided an outline of reasons for the sale on November 25, 2019. Further, Lomiko  will be reimbursed $ 193,614.32 in expenses paid by Lomiko on behalf of Promethieus Tech.  This transaction was approved by shareholders of both Lomiko Metals Inc. and Promethieus Tech  Lomiko Technologies Inc. is the owner of 18.15% of SHD Smart Home Devices Ltd. and 40% of Graphene Energy Storage Devices.  Lomiko was a founding shareholder of Promethieus Tech and currently owns 20% of that company.  The transaction was reviewed by the applicable regulatory bodies.  The transaction was considered a non-arms length transaction as Mr. A. Paul Gill is a Director and a significant shareholder of all the entities involved.

As announced December 3, 2018, Promethieus Technologies Inc. changed it’s mandate to focus on Future Tech investments and has reviewed investment opportunities in electric vehicle infrastructure, clean energy, the Internet of Things (IoT) as well as clean-tech and green tech materials related to these technologies. 

For more information on Lomiko Metals, SHD Smart Home Devices or Promethieus, review the website at www.lomiko.com, www.shddevices.com and www.promethieus.com, contact A. Paul Gill at 604-729-5312 or email: [email protected].

On Behalf of the Board

“Jacqueline Michael”

Director, Chief Financial Officer

We seek safe harbor.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange), or the DCSX  accept responsibility for the adequacy or accuracy of this release.

A. Paul Gill
Lomiko Metals Inc. (TSX-V: LMR)
6047295312
[email protected]